Section Arrow
ELAN.NYSE
- Elanco Animal Health
Quotes are at least 15-min delayed:2025/02/23 10:14 EST
Last
 11.02
-0.11 (-0.99%)
Day High 
11.495 
Prev. Close
11.13 
1-M High
12.7 
Volume 
7.33M 
Bid
10.95
Ask
11.15
Day Low
10.8 
Open
11.185 
1-M Low
10.765 
Market Cap 
5.50B 
Currency USD 
P/E 27.15 
%Yield -- 
10-SMA 11.44 
20-SMA 11.74 
50-SMA 11.91 
52-W High 18.8 
52-W Low 10.765 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
0.41/1.09
Enterprise Value
11.24B
Balance Sheet
Book Value Per Share
13.20
Cash Flow
Cash Flow Yield
0.09
Income Statement
Total Revenue
4.42B
Operating Revenue Per Share
8.83
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
UPCUniverse Pharmaceuticals Inc0.2003+0.0578+40.56%-- 
TLRYTilray Brands0.9452+0.0775+8.93%-- 
CGCCanopy Growth Corp1.615+0.005+0.31%-- 
TXMDTherapeuticsMD1.291+0.281+27.82%0.39PE
TEVATeva Pharmaceutical Industries Limited16.74-0.26-1.53%-- 
Quotes are at least 15-min delayed:2025/02/23 10:14 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal productsused in cattle, sheep, goats, and swine production.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.